
Karl I. Tamai
Supervisory Patent Examiner (ID: 10440, Phone: (571)272-2036 , Office: P/2800 )
| Most Active Art Unit | 2834 |
| Art Unit(s) | 2800, 2102, 2834 |
| Total Applications | 1170 |
| Issued Applications | 751 |
| Pending Applications | 67 |
| Abandoned Applications | 352 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18610812
[patent_doc_number] => 20230277542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => Topical Pharmaceutical Compositions Comprising 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4,4-Dimethylpent-2-Enenitrile
[patent_app_type] => utility
[patent_app_number] => 18/153528
[patent_app_country] => US
[patent_app_date] => 2023-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18153528
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/153528 | Topical Pharmaceutical Compositions Comprising 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4,4-Dimethylpent-2-Enenitrile | Jan 11, 2023 | Abandoned |
Array
(
[id] => 18418362
[patent_doc_number] => 20230172820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => Compositions Containing Microcapsules
[patent_app_type] => utility
[patent_app_number] => 18/150292
[patent_app_country] => US
[patent_app_date] => 2023-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150292
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/150292 | Compositions containing microcapsules | Jan 4, 2023 | Issued |
Array
(
[id] => 19883093
[patent_doc_number] => 12268777
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Compositions and methods for treating eosinophilic disorders
[patent_app_type] => utility
[patent_app_number] => 18/150152
[patent_app_country] => US
[patent_app_date] => 2023-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 30
[patent_no_of_words] => 16162
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150152
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/150152 | Compositions and methods for treating eosinophilic disorders | Jan 3, 2023 | Issued |
Array
(
[id] => 20670878
[patent_doc_number] => 12611373
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-28
[patent_title] => Skincare composition and process for creating sulforaphane
[patent_app_type] => utility
[patent_app_number] => 18/148756
[patent_app_country] => US
[patent_app_date] => 2022-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 0
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18148756
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/148756 | Skincare composition and process for creating sulforaphane | Dec 29, 2022 | Issued |
Array
(
[id] => 18346991
[patent_doc_number] => 20230135101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => BIOABSORBABLE POLYMERIC COMPOSITION FOR A MEDICAL DEVICE
[patent_app_type] => utility
[patent_app_number] => 18/146022
[patent_app_country] => US
[patent_app_date] => 2022-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7504
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18146022
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/146022 | BIOABSORBABLE POLYMERIC COMPOSITION FOR A MEDICAL DEVICE | Dec 22, 2022 | Abandoned |
Array
(
[id] => 18339135
[patent_doc_number] => 20230131084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => PULLULAN CAPSULES
[patent_app_type] => utility
[patent_app_number] => 18/145463
[patent_app_country] => US
[patent_app_date] => 2022-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6406
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18145463
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/145463 | Pullulan capsules | Dec 21, 2022 | Issued |
Array
(
[id] => 18404569
[patent_doc_number] => 20230165920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => COMPOSITION FOR INCREASING SEXUAL DESIRE OR PLEASURE
[patent_app_type] => utility
[patent_app_number] => 18/078921
[patent_app_country] => US
[patent_app_date] => 2022-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18078921
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/078921 | COMPOSITION FOR INCREASING SEXUAL DESIRE OR PLEASURE | Dec 8, 2022 | Abandoned |
Array
(
[id] => 18296819
[patent_doc_number] => 20230106505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => IONTOPHORETIC MICRONEEDLE DEVICE
[patent_app_type] => utility
[patent_app_number] => 18/063085
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063085
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/063085 | IONTOPHORETIC MICRONEEDLE DEVICE | Dec 7, 2022 | Abandoned |
Array
(
[id] => 19599486
[patent_doc_number] => 20240390366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => FORMULATION AND METHOD FOR TOPICAL TREATMENT OF MYCOBACTERIUM ULCERANS IN BURULI ULCERS
[patent_app_type] => utility
[patent_app_number] => 18/714456
[patent_app_country] => US
[patent_app_date] => 2022-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18714456
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/714456 | FORMULATION AND METHOD FOR TOPICAL TREATMENT OF MYCOBACTERIUM ULCERANS IN BURULI ULCERS | Nov 28, 2022 | Pending |
Array
(
[id] => 18869847
[patent_doc_number] => 11857627
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Fractionated radiotherapy and chemotherapy with an oxygen therapeutic
[patent_app_type] => utility
[patent_app_number] => 17/994166
[patent_app_country] => US
[patent_app_date] => 2022-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6619
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17994166
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/994166 | Fractionated radiotherapy and chemotherapy with an oxygen therapeutic | Nov 24, 2022 | Issued |
Array
(
[id] => 20301158
[patent_doc_number] => 12447128
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-21
[patent_title] => Formulations of enzalutamide
[patent_app_type] => utility
[patent_app_number] => 17/985220
[patent_app_country] => US
[patent_app_date] => 2022-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 19135
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17985220
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/985220 | Formulations of enzalutamide | Nov 10, 2022 | Issued |
Array
(
[id] => 18199739
[patent_doc_number] => 20230053259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => DEODORANT COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/979822
[patent_app_country] => US
[patent_app_date] => 2022-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6883
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17979822
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/979822 | Deodorant compositions | Nov 2, 2022 | Issued |
Array
(
[id] => 18210227
[patent_doc_number] => 20230056488
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => COMPOSITION, ARTICLE AND METHOD FOR AFFECTING A MAMMAL
[patent_app_type] => utility
[patent_app_number] => 17/971462
[patent_app_country] => US
[patent_app_date] => 2022-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8957
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17971462
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/971462 | COMPOSITION, ARTICLE AND METHOD FOR AFFECTING A MAMMAL | Oct 20, 2022 | Pending |
Array
(
[id] => 19641252
[patent_doc_number] => 20240415772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => IONIZABLE CATIONIC LIPID FOR MESSENGER RNA DELIVERY
[patent_app_type] => utility
[patent_app_number] => 18/702902
[patent_app_country] => US
[patent_app_date] => 2022-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18702902
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/702902 | IONIZABLE CATIONIC LIPID FOR MESSENGER RNA DELIVERY | Oct 20, 2022 | Pending |
Array
(
[id] => 18319512
[patent_doc_number] => 20230117640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => PUTRESCINE TOPICAL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/046221
[patent_app_country] => US
[patent_app_date] => 2022-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15467
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046221
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/046221 | PUTRESCINE TOPICAL FORMULATIONS | Oct 12, 2022 | Abandoned |
Array
(
[id] => 18610696
[patent_doc_number] => 20230277426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => TOPICAL SKIN COMPOSITIONS FOR TREATING WRINKLES
[patent_app_type] => utility
[patent_app_number] => 17/965483
[patent_app_country] => US
[patent_app_date] => 2022-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17965483
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/965483 | Topical skin compositions for treating wrinkles | Oct 12, 2022 | Issued |
Array
(
[id] => 18180616
[patent_doc_number] => 20230041345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => ANTIPERSPIRANT AND DEODORANT COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/961089
[patent_app_country] => US
[patent_app_date] => 2022-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17961089
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/961089 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | Oct 5, 2022 | Pending |
Array
(
[id] => 18412011
[patent_doc_number] => 11666538
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-06
[patent_title] => Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/959681
[patent_app_country] => US
[patent_app_date] => 2022-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19864
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17959681
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/959681 | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof | Oct 3, 2022 | Issued |
Array
(
[id] => 19752740
[patent_doc_number] => 20250041305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => PHARMACEUTICAL COMPOSITION OF SEPIAPTERIN
[patent_app_type] => utility
[patent_app_number] => 18/696567
[patent_app_country] => US
[patent_app_date] => 2022-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14199
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18696567
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/696567 | PHARMACEUTICAL COMPOSITION OF SEPIAPTERIN | Sep 28, 2022 | Pending |
Array
(
[id] => 18443568
[patent_doc_number] => 11679119
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-20
[patent_title] => Bortezomib compositions
[patent_app_type] => utility
[patent_app_number] => 17/934901
[patent_app_country] => US
[patent_app_date] => 2022-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20951
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934901
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/934901 | Bortezomib compositions | Sep 22, 2022 | Issued |